BridgeMD
New treatment option for First Episode Psychosis (FEP)
Official title Self-administered COgnitive Personalized Training in Early Psychosis
ClinicalTrials.gov ID: NCT06634446
What this study is testing
- What it's testing
- The overall objective of SCOPe is to improve early intervention in psychosis by providing an innovative eHealth tool that will enable personalized cognitive training, adapted to the individual's cognitive abilities. Cognitive remediation improves quality of life and functional outcome in patients with chronic psychosis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 35. Healthy volunteers may be eligible.
You may be able to join if
- Adolescent and young adults, both genders, aged 16 to 35,
- Seeking help in one of the recruiting centers,
- Newly diagnosed as experiencing an Episode of Psychosis (reaching criteria as described in the Comprehensive Assessment of at Risk Mental States...
- Written informed consent signed (and from one legal guardian for minors).
You likely can't join if
- Severe and unstabilized medical conditions,
- Insufficient level in reading and/or French language,
- Absence of medical insurance,
- Participation in another intervention trial,
- Enforced hospitalization (ASPDT, ASPPI, ASPRE),
- Intellectuel Deficiency (IQ\<70), and / or sensorimotor deficits incompatible with the cognitive training,
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.